Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity.
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
Federal health officials have confirmed unsettling details about the first United States case of severe bird flu.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback